Phase II study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19.

Arantxa HorgaDaniel R KuritzkesJohn J KowalczykKeith PietropaoloBruce BelangerKai LinKristen PerkinsJanet Hammond

Published in: Future virology (2023)

NCT04396106 (ClinicalTrials.gov).

Keyphrases